Groundbreaking: Amicus Surges as the FDA Changes Its Tune on Fabry Disease Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Groundbreaking: Amicus Surges as the FDA Changes Its Tune on Fabry Disease Drug" ALT"Groundbreaking: Amicus Surges as the FDA Changes Its Tune on Fabry Disease Drug"July 11, 2017By…

Continue ReadingGroundbreaking: Amicus Surges as the FDA Changes Its Tune on Fabry Disease Drug

Neothetics to Slash an Unknown Number of Jobs, Review Strategic Alternatives

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-job-cuts6.jpg " NAME"Neothetics to Slash an Unknown Number of Jobs, Review Strategic Alternatives" ALT"Neothetics to Slash an Unknown Number of Jobs, Review Strategic Alternatives"July 11, 2017By Alex Keown, BioSpace.com...…

Continue ReadingNeothetics to Slash an Unknown Number of Jobs, Review Strategic Alternatives

Why Amgen Needs an Acquisition to Keep Up with Immuno-Oncology Competitors

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-amgen.jpg" NAME"Why Amgen Needs an Acquisition to Keep Up with Immuno-Oncology Competitors" ALT"Why Amgen Needs an Acquisition to Keep Up with Immuno-Oncology Competitors"July 10, 2017By Mark Terry, BioSpace.com Breaking...…

Continue ReadingWhy Amgen Needs an Acquisition to Keep Up with Immuno-Oncology Competitors